FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to development of new complex interferon-based agent containing antioxidant complex for inflammatory-infectious diseases of various aethiology, and medicinal agent additionally contains calcium patothenat having antitoxic activity, antiinflammatory and regenerative action, as well as antibacterial or antiseptic components providing intensified antimicrobial activity or probiotics (and/or prebiotics), normalising microbiocoenosis, enabling immune power restoration, gastrointestinal tract activity restoration.
EFFECT: reduced risk of complications; lowered toxicity effect of antibiotic-therapy and increased therapy efficiency.
9 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
| MEDICINE WITH IMMUNE MODIFYING, ANTIVIRUS, ANTIBACTERIAL ANTIOXIDISING, MEMBRANE STABILISING, CARTILAGE AND CONNECTIVE TISSUE GROWTH STIMULATING EFFECT | 2007 |
|
RU2349339C1 |
| STABILISED IMMUNE-CORRECTIVE DRUG VIFERON-FORTE FOR TREATING INFECTIOUS-INFLAMMATORY DISEASES | 2008 |
|
RU2381812C1 |
| IMMUNOCORRECTIVE AGENT FOR TREATING DISEASES OF VIRAL AETIOLOGY | 2007 |
|
RU2411039C2 |
| AGENT FOR SEVERE INFECTIOUS DISEASES AND MIXED INFECTIONS | 2008 |
|
RU2366450C1 |
| PHARAMCEUTICAL AGENT FOR TREATMENT OF VIRAL AND DIFFERENT INFECTIONS | 2006 |
|
RU2323738C1 |
| PROLONGED INTERFERON SOLUTION | 2004 |
|
RU2270692C1 |
| CURATIVE AGENT | 2005 |
|
RU2283133C1 |
| RECTAL SUPPOSITORY MEDICINAL PRODUCT AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2689320C1 |
| RECTAL SUPPOSITORIES AND DEVICE FOR INTRODUCTION THEREOF | 1991 |
|
RU2024253C1 |
